Dataset Information


The gene-treatment interaction of paraoxonase-1 gene polymorphism and statin therapy on insulin secretion in Japanese patients with type 2 diabetes: Fukuoka diabetes registry.

ABSTRACT: BACKGROUND:Although statins deteriorate glucose metabolism, their glucose-lowering effects have emerged in some situations. Here, we assessed whether these effects are a consequence of statins' interaction with paraoxonase (PON)1 enzyme polymorphism. METHODS:Adult Japanese type 2 diabetes patients (n?=?3798) were enrolled in a cross-sectional study. We used Q192R polymorphism of the PON1 gene as a representative single-nucleotide polymorphism and focused on the effects of the wild-type Q allele, in an additive manner. For patients with and without statin therapy, the associations of this allele with fasting plasma glucose (FPG), HbA1c, C-peptide, HOMA2-%?, and HOMA2-IR were investigated separately using a linear regression model, and were compared between groups by testing interactions. Sensitivity analyses were performed using propensity score to further control the imbalance of characteristics between groups. RESULTS:Among patients with statin therapy, there were linear associations of the number of Q alleles with decreased FPG and HbA1c, and with increased serum C peptide and HOMA2-%? (all P?

PROVIDER: S-EPMC5728066 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC6004736 | BioStudies
| S-EPMC5824408 | BioStudies
| S-EPMC6074118 | BioStudies
| S-EPMC2755129 | BioStudies
| S-EPMC8341610 | BioStudies
| S-EPMC3101657 | BioStudies
| S-EPMC5308615 | BioStudies
| S-EPMC4904111 | BioStudies
| S-EPMC3304338 | BioStudies
| S-EPMC5753010 | BioStudies